APA (7th ed.) Citation

K, A., CL, C., S, Z., S, K., K, H., D, S., . . . M, M. (2013). MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines. Cancer biology & therapy, 14(10), 932. https://doi.org/10.4161/cbt.25939

Chicago Style (17th ed.) Citation

K, Almhanna, Cubitt CL, Zhang S, Kazim S, Husain K, Sullivan D, Sebti S, and Malafa M. "MK-2206, an Akt Inhibitor, Enhances Carboplatinum/paclitaxel Efficacy in Gastric Cancer Cell Lines." Cancer Biology & Therapy 14, no. 10 (2013): 932. https://doi.org/10.4161/cbt.25939.

MLA (9th ed.) Citation

K, Almhanna, et al. "MK-2206, an Akt Inhibitor, Enhances Carboplatinum/paclitaxel Efficacy in Gastric Cancer Cell Lines." Cancer Biology & Therapy, vol. 14, no. 10, 2013, p. 932, https://doi.org/10.4161/cbt.25939.